Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-08-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于预计2020年度日常关联交易事项的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected related party transactions for the year 2020 by Tianjin Ruipu Biotechnology Co., Ltd. It details the nature, estimated amounts, and approval process of these related party transactions. It includes information about the board and independent directors' opinions, the supervisory board's opinion, and references to meeting resolutions. The document is not a full financial report but a regulatory announcement about related party transactions, which is a common disclosure under regulatory requirements. The document length is 3674 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial statement or comprehensive financial analysis present. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2020-08-26 Chinese
关于员工持股计划存续期到期拟延期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biological Technology Co., Ltd. regarding the extension of the duration of its employee stock ownership plan. It details the background of the plan, the original duration, the expiration date, and the decision to extend the plan by one year. The document does not contain financial statements or detailed financial performance data. It is a corporate announcement about a capital-related employee incentive plan, specifically about the extension of the plan's term. This fits best under the category of Capital/Financing Update (CAP), as it relates to changes in the company's capital structure or financing arrangements through employee stock plans.
2020-08-21 Chinese
关于部分董事、监事及高级管理人员减持股份的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding planned share reductions by certain directors, supervisors, and senior management of the company. It details the number of shares held, the planned reduction amounts, timing, methods, and related risk disclosures. The content focuses on insider share transactions and compliance with relevant securities laws and stock exchange rules. There is no financial performance data, earnings information, or report publication mentioned. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and it is not an announcement of a report publication or a certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-08-07 Chinese
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2020 third extraordinary general meeting of shareholders of Tianjin Ruipu Biotechnology Co., Ltd. It includes voting results on various proposals related to the issuance of convertible bonds, legal opinions on the meeting's validity, and procedural details. The content focuses on the official results of shareholder votes at a general meeting, including voting percentages and approval status for each agenda item. There is no financial data or report analysis, nor is it a presentation or management discussion. The document is not a report publication announcement since it contains substantive voting results and meeting details. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-07-23 Chinese
2020年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, voting procedures, and results of the 2020 third extraordinary general meeting (临时股东大会) of Tianjin Ruipu Biotechnology Co., Ltd. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes on various proposals related to the issuance of convertible bonds. The document is not a financial report, earnings release, or management discussion, but rather a formal legal opinion on the shareholder meeting and its resolutions. This type of document corresponds to the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2020-07-23 Chinese
关于高级管理人员违规减持公司股票的情况说明及致歉公告
Director's Dealing Classification · 100% confidence The document is a public announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding a violation by a senior management member (the Vice General Manager) who illegally reduced his shareholding without prior disclosure. The announcement details the share reduction, the violation of regulations, and an apology from the individual. It does not contain financial statements, earnings data, or detailed financial analysis. It is a disclosure about insider share transactions by a company director/executive. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused on this specific insider transaction, not a broader financial or regulatory report.
2020-07-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.